How emerging therapies and lifestyle strategies may reshape cognitive outcomes in diabetes
Watch the full video on YouTube to explore the evolving evidence linking diabetes and dementia, and how prevention strategies may reshape long-term outcomes.
In this episode, Prof. Gill Livingston (Unioversity College London) and Prof. Thomas van Sloten (UMC Utrecht) discuss:
The increased risk of dementia in people with diabetes
Why type 2 diabetes carries a particularly strong association
The impact of cognitive decline on diabetes self-management and quality of life
Prevention strategies, including vascular risk management and lifestyle modification
Emerging evidence on GLP-1 receptor agonists and SGLT2 inhibitors
The need for clinical trials with cognition and dementia as primary outcomes
This episode highlights a major shift: brain health is now central to long-term diabetes care.
Explore the related session from the EASD 2025 Annual Meeting and view our speakers’ profiles:
Prof. Gill Livingston
Prof. Thomas van Sloten
For more expert conversations, visit our podcast archive.
